Literature DB >> 25431349

Genetics of familial melanoma: 20 years after CDKN2A.

Lauren G Aoude1, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward.   

Abstract

Twenty years ago, the first familial melanoma susceptibility gene, CDKN2A, was identified. Two years later, another high-penetrance gene, CDK4, was found to be responsible for melanoma development in some families. Progress in identifying new familial melanoma genes was subsequently slow; however, with the advent of next-generation sequencing, a small number of new high-penetrance genes have recently been uncovered. This approach has identified the lineage-specific oncogene MITF as a susceptibility gene both in melanoma families and in the general population, as well as the discovery of telomere maintenance as a key pathway underlying melanoma predisposition. Given these rapid recent advances, this approach seems likely to continue to pay dividends. Here, we review the currently known familial melanoma genes, providing evidence that most additionally confer risk to other cancers, indicating that they are likely general tumour suppressor genes or oncogenes, which has significant implications for surveillance and screening.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  familial; genetics; melanoma

Mesh:

Substances:

Year:  2015        PMID: 25431349     DOI: 10.1111/pcmr.12333

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  44 in total

1.  Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.

Authors:  Dilys M Parry; Mary L McMaster; Norbert J Liebsch; Nicholas J Patronas; Martha M Quezado; Deborah Zametkin; Xiaohong R Yang; Alisa M Goldstein
Journal:  J Neurosurg       Date:  2020-06-19       Impact factor: 5.115

2.  A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.

Authors:  Craig C Teerlink; Chad Huff; Jeff Stevens; Yao Yu; Sheri L Holmen; Mark R Silvis; Kirby Trombetti; Hua Zhao; Douglas Grossman; James M Farnham; Jingran Wen; Julio C Facelli; Alun Thomas; Markus Babst; Scott R Florell; Laurence Meyer; John J Zone; Sancy Leachman; Lisa A Cannon-Albright
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

Review 3.  [Molecular diagnostics in melanoma].

Authors:  R Lang; J W Bauer; M Laimer
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

Review 4.  Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).

Authors:  Mijke Visser; Nienke van der Stoep; Nelleke Gruis
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

Review 5.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

Review 6.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

7.  Editorial for Cancer Virtual Issue.

Authors:  Benjamin E Blass
Journal:  ACS Med Chem Lett       Date:  2017-12-14       Impact factor: 4.345

8.  Age-Specific Incidence of Melanoma in the United States.

Authors:  Kelly G Paulson; Deepti Gupta; Teresa S Kim; Joshua R Veatch; David R Byrd; Shailender Bhatia; Katherine Wojcik; Aude G Chapuis; John A Thompson; Margaret M Madeleine; Jennifer M Gardner
Journal:  JAMA Dermatol       Date:  2020-01-01       Impact factor: 10.282

Review 9.  Genetics of metastasis: melanoma and other cancers.

Authors:  Noel Turner; Olivia Ware; Marcus Bosenberg
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

Review 10.  Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.

Authors:  Thomas Wiesner; Heinz Kutzner; Lorenzo Cerroni; Martin C Mihm; Klaus J Busam; Rajmohan Murali
Journal:  Pathology       Date:  2016-01-18       Impact factor: 5.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.